Chi Shing Cho

Title: Chi Shing Cho: Innovator in Lung Cancer Diagnostics

Introduction

Chi Shing Cho is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of lung cancer diagnostics through his innovative research and patented methodologies. His work focuses on identifying serum biomarkers that can aid in the early detection of lung cancer.

Latest Patents

Chi Shing Cho holds a patent for "Serum biomarkers in lung cancer." This patent outlines certain biomarkers and biomarker combinations that are useful in qualifying lung cancer status in a subject. The diagnostic methodology he developed employs these biomarkers to detect whether a subject has lung cancer, potentially leading to earlier and more effective treatment options.

Career Highlights

Throughout his career, Chi Shing Cho has worked with reputable institutions, including Queen Elizabeth Hospital and Vermillion Corporation. His experience in these organizations has allowed him to refine his expertise in medical diagnostics and contribute to advancements in cancer research.

Collaborations

Chi Shing Cho has collaborated with several professionals in his field, including Timothy Tak Chun Yip and Siu Kie Au. These collaborations have further enhanced his research and development efforts in lung cancer diagnostics.

Conclusion

Chi Shing Cho's innovative work in identifying serum biomarkers for lung cancer demonstrates his commitment to improving diagnostic methodologies. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for significant advancements in medical diagnostics.